Blockade of blocking antibodies in Guillain-Barré syndromes: “Unblocking” the mystery of action of intravenous immunoglobulin


  • Marinos C. Dalakas MD

    1. Neuromuscular Diseases Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD
    Search for more papers by this author

  • This article is a US Government work and, as such, is in the public domain in the United States of America.

No abstract is available for this article.